Ranucci Marco, Isgrò Giuseppe, Giomarelli Pier Paolo, Pavesi Marco, Luzzani Aldo, Cattabriga Iolter, Carli Manuela, Giomi Paolo, Compostella Antonio, Digito Antonio, Mangani Valerio, Silvestri Vito, Mondelli Enzo
Department of Cardiothoracic Anesthesia, Istituto Policlinico S. Donato, Milan, Italy.
Crit Care Med. 2003 Jan;31(1):52-9. doi: 10.1097/00003246-200301000-00008.
To evaluate a new antimicrobial treatment for central venous catheters in comparison with a traditional treatment, by assessing the catheter colonization and catheter-related bloodstream infection rates in two groups of patients.
Multiple-center, prospective randomized study.
The medical and surgical departments of ten institutions.
Patients requiring a central venous catheter for medical or surgical pathologies between June 2000 and November 2001.
Patients in the control group received a conventional benzalkonium-treated double-lumen central venous catheter, while patients in the oligon group received an oligon-treated (polyurethane combined with silver, carbon, and platinum) catheter with the same characteristics. Data collection included demographics, preexisting clinical conditions, main pathology, catheter insertion, and management data. Catheter colonization was defined as the growth of > or = 15 colony-forming units in culture of catheter segments by the roll-plate method, or > or = 1000 colony-forming units for the sonication method, and catheter-related bloodstream infection was defined as isolation of the same organism from the colonized catheter and from the peripheral blood of a patient with clinical signs of bloodstream infection.
Data were obtained from 545 catheters. Of these, 132 catheters (24.2%) were positive for colonization. Patients in the oligon group demonstrated a lower risk for catheter colonization in the overall population (relative risk, 0.63; 95% confidence interval, 0.46-0.86; p = .003) and in the surgical subgroup (relative risk, 0.5; 95% confidence interval, 0.33-0.76;p = .001). Significant differences between groups were detected for coagulase-negative staphylococci and Gram-negative bacilli colonization rates. Twenty-one patients (3.8%) were positive for catheter-related bloodstream infection, without significant differences between control and oligon groups.
Oligon treatment is effective in limiting the catheter colonization rate. Due to the limited amount of events, this study lacked the power to detect significant differences in terms of catheter-related bloodstream infection rate.
通过评估两组患者的导管定植情况和导管相关血流感染率,比较一种新型中心静脉导管抗菌治疗方法与传统治疗方法的效果。
多中心前瞻性随机研究。
十家机构的内科和外科科室。
2000年6月至2001年11月期间因内科或外科疾病需要中心静脉导管的患者。
对照组患者接受常规苯扎氯铵处理的双腔中心静脉导管,而oligon组患者接受具有相同特征的oligon处理(聚氨酯与银、碳和铂结合)的导管。数据收集包括人口统计学、既往临床情况、主要病理、导管插入和管理数据。导管定植定义为通过滚板法在导管段培养物中生长≥15个菌落形成单位,或通过超声处理法生长≥1000个菌落形成单位,导管相关血流感染定义为从定植导管和有血流感染临床体征患者的外周血中分离出相同微生物。
从545根导管获取数据。其中,132根导管(24.2%)定植阳性。oligon组患者在总体人群中导管定植风险较低(相对风险,0.63;95%置信区间,0.46 - 0.86;p = 0.003),在外科亚组中也是如此(相对风险,0.5;95%置信区间,0.33 - 0.76;p = 0.001)。在凝固酶阴性葡萄球菌和革兰氏阴性杆菌定植率方面检测到组间存在显著差异。21例患者(3.8%)导管相关血流感染阳性,对照组和oligon组之间无显著差异。
oligon处理在限制导管定植率方面有效。由于事件数量有限,本研究缺乏检测导管相关血流感染率显著差异的能力。